Charles Spicer has stepped down as executive director at Ixico.

Spicer had been involved with Ixico since 2011, first as an advisor on corporate strategy and then as a member of the board from July 2013 onwards.  He was involved in the reverse takeover of Phytopharm in October 2013 and, more recently, the company’s acquisition of Optimal Medicine.

Ixico chairman Andrew Richards said: “I would like thank Charles for his support over the past five years.  He has played a pivotal role in developing Ixico’s corporate profile and we appreciate the advice and expertise that he has provided.  We are delighted that Charles will remain with the company and continue to provide guidance in his ongoing non-executive role as we grow the business”.